ArticleMethods in molecular biology (Clifton, N.J.)2027
Flow Cytometry in Human Cells Exposed to Tick Salivary Proteins.
Article in Methods in molecular biology (Clifton, N.J.), 2027. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The Indirect basophil activation test (iBAT) is a flow cytometry-based assay in which basophils are first passively sensitized with patient-derived IgE and subsequently stimulated with the allergen of interest to assess activation markers on the cell surface. This method was implemented by using the human KU812 cell line to investigate basophil activation mechanisms triggered by tick-derived biomolecules. Unlike the traditional BAT, the iBAT approach avoids variability from non-responder patients and donor-dependent differences, providing a stable and reproducible in vitro model. KU812 cells were differentiated with IL-4, primed with serum from a human patient diagnosed with α-Gal syndrome (AGS), and stimulated with increasing concentrations of tick salivary proteins, including metalloprotease (A0A0K8RCY8) and antigen p23 (A0A0K8RKR7). Activation was assessed by flow cytometry through CD63 and CD203c expression. Dose-response curves were analyzed to determine CDmax, EC₅₀, and AUC, enabling comparison of allergenic potency and overall activation. This iBAT model offers a controlled and reproducible method to explore IgE-mediated mechanisms relevant to tick exposure and the pathophysiology of AGS.
Indexed as
Identifiers
42918984What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.